UK markets closed

IDEAYA Biosciences, Inc. (30J.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
37.60+0.40 (+1.08%)
As of 08:03AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
15,505
23,385
50,931
27,941
19,538
Operating expenses
Research development
144,454
129,508
89,536
58,158
39,698
Selling general and administrative
30,218
28,306
23,897
20,051
15,184
Total operating expenses
174,672
157,814
113,433
78,209
54,882
Operating income or loss
-159,167
-134,429
-62,502
-50,268
-35,344
Income before tax
-131,844
-112,961
-58,655
-49,762
-34,495
Income from continuing operations
-131,844
-112,961
-58,655
-49,762
-34,495
Net income
-131,844
-112,961
-58,655
-49,762
-34,495
Net income available to common shareholders
-131,844
-112,961
-58,655
-49,762
-34,495
Basic EPS
-1.98
-1.96
-1.42
-1.41
-1.40
Diluted EPS
-1.98
-1.96
-1.42
-1.41
-1.40
Basic average shares
53,238
57,520
41,445
35,252
24,722
Diluted average shares
53,238
57,520
41,445
35,252
24,722